Estrella Immunopharma share price logo

Estrella Immunopharma

NASDAQ: ESLA

$0.71

-0.02

(-2.33%)

as on

Estrella Immunopharma Stock Performance

as on August 29, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $0.63
    $0.73
    downward going graph

    11.27%

    Downside

    2.82%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.68
    $3.15
    downward going graph

    4.49%

    Downside

    343.66%

    Upside

    downward going graph

Estrella Immunopharma share price movements today

Previous Close
$0.72
Open
$0.73
Volume
606.0K
Market Cap
$31.8M
Day's Low - High
$0.63 - $0.73
52 Week Low - High
$0.68 - $3.15

Estrella Immunopharma Historical Returns

1 Month Return
-3.55 %
3 Month Return
-36.68 %
1 Year Return
-24.8 %
3 Year Return
0 %
5 Year Return
0 %

Estrella Immunopharma Stock Fundamentals & Key Indicators

Check Estrella Immunopharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$31.8M

EPS (TTM)

-0.2462

Dividend Yield

0.00%

PE Ratio (TTM)

-2.98

Industry PE ratio

-1.6366929133858268

PEG Ratio

-0.1558163870239402

Return On Equity TTM

121.72%

Estrella Immunopharma Stock Valuation

Track how Estrella Immunopharma P/E has moved over time to understand its valuation trends.

Estrella Immunopharma in the last 5 years

  • Overview

  • Trends

Lowest (-59.53x)

December 31, 2022

Today (-4.46x)

December 31, 2025

Industry (-1.64x)

December 31, 2025

Highest (-4.46x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -4.46x

Estrella Immunopharma vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Estrella Immunopharma with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NA$31.8MNA-2.980.00%NA
BUY$46.2B675.69%NA0.00%NA
BUY$138.7B173.88%31.9286.04%NA
BUY$59.7B-62.65%-7.98-12.57%NA
BUY$85.8B21.77%19.984.86%0.44%

Stock Returns calculator for Estrella Immunopharma Stock including INR - Dollar returns

The Estrella Immunopharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Estrella Immunopharma investment value today

Current value as on today

₹80,003

Returns

-₹19,997

(-20%)

Returns from Estrella Immunopharma Stock

-₹26,042 (-26.04%)

Dollar Impact

₹6,044 (+6.04%)

Estrella Immunopharma Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
0
-3
-3
-1
-2
-5
-4
0
-2
-2
EBITDA
0
-3
-3
-1
-2
-5
-4
0
-2
-2
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
0
-3
-3
-1
-2
-5
-4
0
-2
-2
Income Tax Expense
-
0
-
0
0
0
-
0
-
-
Net Income
0
-3
-3
-1
-2
-5
-4
0
-2
-2
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Estrella Immunopharma Annual Profit & Loss

All numbers in Millions USD

Jun 2021
Jun 2022
Dec 2022
Jun 2024
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
Operating Income
0
-1
-1
-7
-8
-13
EBITDA
0
0
0
-7
-8
-13
Interest Expense
-
-
-
-
-
-
Depreciation
0
0
0
-
-
-
Income Before Tax
0
-1
0
-7
-8
-13
Income Tax Expense
-
-
0
0
0
0
Net Income
0
-1
0
-7
-8
-13
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Estrella Immunopharma Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
0
-3
-3
-1
-2
-5
-4
0
-2
-2
Operating Cash Flow
-15
0
-2
0
0
0
0
0
-6
-1
Investing Cash Flow
4
-
-
-
-
-
-
-
-
-
Financing Cash Flow
13
0
0
0
0
1
1
0
7
0
Change in Cash
4
0
-2
0
0
0
0
0
0
-1

Estrella Immunopharma Annual Cash Flow

All numbers in Millions USD

Jun 2021
Jun 2022
Dec 2022
Jun 2024
Dec 2024
Dec 2025
Net Income
0
-1
0
-7
-8
-13
Operating Cash Flow
0
-1
-1
-16
-3
-1
Investing Cash Flow
-
-
36
4
-
-
Financing Cash Flow
0
5
-35
12
0
2
Change in Cash
-
4
0
1
0
0

Mutual Funds that own Estrella Immunopharma Stock

Check out the Mutual Funds with significant holdings in Estrella Immunopharma.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
0.879282%
382469
Fidelity Concord Street Trust
0.215031%
93534

Global Institutional Holdings in Estrella Immunopharma

Funds
Holdings
Vanguard
0.96%
iShares
0.12%

Insights on Estrella Immunopharma

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 472.8% return, outperforming this stock by 505.6%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, ESLA stock has moved down by -9.5%

About Estrella Immunopharma

Estrella Immunopharma, Inc., a clinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidate is EB103, which is in Phase I/II clinical trial, for the treatment of diffuse large B-cell lymphoma; EB104, which is in pre-clinical trial, to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia; and EB201, which is in pre-clinical trial, for the treatment of systemic lupus erythematosus. It offers ARTEMIS, a cell receptor platform to develop and commercialize T-cell therapies targeting CD19 and CD22 for the treatment of hematologic malignancies. It has a collaborative agreement with Eureka and Imugene Limited for the development of solid tumor treatments using Imugene's product candidate CF33-CD19t in conjunction with EB103. Estrella Immunopharma, Inc. was founded in 2006 and is headquartered in EmeryVille, California. Estrella Immunopharma, Inc. is a subsidiary of Eureka Therapeutics, Inc.
OrganisationEstrella Immunopharma
Headquarters5858 Horton Street, EmeryVille, CA, United States, 94608
IndustryBiotechnology
CEODr. Cheng Liu Ph.D.
E-voting on sharesClick here to vote

Key Management of Estrella Immunopharma

Name

Title

Mr. Jiandong Xu

Chief Financial Officer

Dr. Cheng Liu Ph.D.

CEO, President & Director

FAQs

What is Estrella Immunopharma share price today?

Estrella Immunopharma share price today is $0.71 as on at the close of the market. Estrella Immunopharma share today touched a day high of $0.73 and a low of $0.63.

What is the 52 week high and 52 week low for Estrella Immunopharma share?

Estrella Immunopharma share touched a 52 week high of $3.15 on and a 52 week low of $0.68 on . Estrella Immunopharma stock price today i.e. is closed at $0.71,which is 77.46% down from its 52 week high and 4.70% up from its 52 week low.

What is Estrella Immunopharma's market capitalisation today?

Estrella Immunopharma market capitalisation is $0.00T as on .

How to invest in Estrella Immunopharma Stock (ESLA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Estrella Immunopharma on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Estrella Immunopharma Shares that will get you 2.1127 shares as per Estrella Immunopharma share price of $0.71 per share as on August 29, 2026 at 8:45 am IST.

What is the minimum amount required to buy Estrella Immunopharma Stock (ESLA) from India?

Indian investors can start investing in Estrella Immunopharma (ESLA) shares with as little as ₹95.38 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹953.80 in Estrella Immunopharma stock (as per the Rupee-Dollar exchange rate as on ). Based on Estrella Immunopharma share’s latest price of $0.71 as on August 29, 2026 at 8:45 am IST, you will get 14.0845 shares of Estrella Immunopharma. Learn more about fractional shares .